Danish researchers have identified several new prognostic factors for relapse in patients with clinical stage I testicular seminoma, according to results published in the Journal of Clinical Oncology (JCO).1
“The identified prognostic factors enable providers and patients to make more informed decisions about post-orchiectomy management, and could be incorporated into clinical guidelines and be used in future studies investigating risk adapted follow-up and treatment strategies,” Michael…
Read the full article here